Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$271.38M Raised in 14 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Vensica Medical

start up
Israel - Netanya, IL
  • 29/10/2024
  • Unknown
  • $11,000,000

Vensica Medical is a medical device company that is designing and developing and Ultrasound catheter for the treatment of bladder cancer.
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).
Using Vensica’s device, the drug will be instilled in a quick, pain-free procedure subsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.


Related People

Avner GevaCo Founder

Avner Geva United States - Brooklyn, New York

A serial life sciences entrepreneur and seasoned healthcare manager, Avner is the current co-
founder and CEO of Vensica Medical, a company that is developing the Vibe – a catheter that
unlocks the power of therapeutic ultrasound to deliver drugs to the bladder wall.

Since founding Vensica, he has steered the company from inception to Phase II trials,
successfully raising $30 million and securing a strategic partnership with Merz Therapeutics,
including in-licensing Xeomin, a drug generating approximately $1 billion in revenue.

Avner is also the co-founder and a Board Member of an oncology startup, IntraGel Therapeutics,
playing a pivotal role in its seed financing, clinical pipeline development, and strategic
collaborations.

As Entrepreneur in Residence (EIR) at Yale Ventures and biotech principal, Avner also
collaborates with VCs and scouts for exciting deals, overseeing due diligence, and managing
deal flow.

Avner earned a B.Sc from Yale University and a M.Sc from the Technion - Israel Institute of
Technology. He has also been recognized with numerous patents, publications, and awards for
his pioneering research and inventions.

For healthcare fundraising or to explore new ventures, please reach out to to;
avner.geva@gmail.com